CURRENT ISSUE Current Issue Cover
VOL 10 NO 5 • JULY 2019
IN THIS ISSUE

Improvements in Advance Care Planning Can Translate to Patient Comfort

Pamela Hallquist Viale, RN, MS, CNS, ANP

Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without B...

Andrew Garcia,(1) PharmD, Corey Frahm,(1) PharmD, Joanne M. Jeter,(2) MD, Ivo Abraham,(1) PhD, RN, Setsuko K. Chambers,(3) MD, Janiel M. Cragun,(3) MD, and Ali McBride,(1) PharmD

A Support Intervention for Family Caregivers of Advanced Cancer Patients

Betty Ferrell,(1) PhD, RN, MA, FAAN, FPCN, CHPN, Kate Kravits,(1) MA, RN, HNB-BS, LPC, NCC, ATR-BC, Tami Borneman,(1) RN, MSN, CNS, FPCN, Sumanta K. Pal,(1) MD, and Janet Lee,(2) EdM

The Integration of Survivorship Care Planning at a Comprehensive Cancer Center

Elizabeth B. McGrath, DNP, APRN, AGACNP-BC, AOCNP®, ACHPN, Anna Schaal, MSN, APRN, and Claire Pace, MSN, APRN

 
Section Seperator

TODAY'S NEWS

FDA Pipeline: Priority Reviews in Prosta...

This week, the U.S. Food and Drug Administration (...

Genomic Landscape of Merkel Cell Carcino...

Researchers have developed the largest descriptive...

Addition of Pemetrexed/Carboplatin to Ge...

In a single-center phase III trial reported in the...

Swallowing-Related Quality of Life After...

In the phase II ORATOR trial reported in The Lance...

Impact of Genes on Total Number and Type...

A study by Duffy et al in the Journal of Investiga...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Immunoglobulin Light-Chain Amyloidosis

Systemic immunoglobulin light-chain (AL) amyloidosis is a rare disorder arising from a plasma cell clone...

Dosing Schedule for Metastatic RCC with Sunitinib

An estimated 73,820 patients in the United States will be diagnosed with renal cell carcinoma...

Ivosidenib: IDH1 Inhibitor for the Treatment of AML

Acute myeloid leukemia is a hematologic malignancy originating from abnormal proliferation of...

Apalutamide for Nonmetastatic Prostate Cancer

Prostate cancer is a male-specific oncologic disease that is one of the top four leading causes of cancer in the U.S...

JADPRO Supplement: CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.